Invention Grant
- Patent Title: Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia
-
Application No.: US16099353Application Date: 2017-05-04
-
Publication No.: US10716813B2Publication Date: 2020-07-21
- Inventor: Maria Felice Brizzi , Giovanni Camussi
- Applicant: UNICYTE EV AG
- Applicant Address: CH Oberdorf
- Assignee: UNICYTE EV AG
- Current Assignee: UNICYTE EV AG
- Current Assignee Address: CH Oberdorf
- Agency: Jacobson Holman, PLLC.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2ea521d4
- International Application: PCT/EP2017/060612 WO 20170504
- International Announcement: WO2017/191234 WO 20171109
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K35/28 ; A61K35/407 ; A61K48/00 ; A61P3/10 ; A61K9/127 ; A61K31/7105
Abstract:
The invention relates to a new therapeutic application of pharmaceutically acceptable carriers containing miR222. In particular, the invention relates to the use of extracellular vesicles (EVs) which contain the microRNA miR222, in the treatment of fibrotic disease caused by hyperglycaemia, such as diabetic nephropathy and/or renal fibrosis.
Public/Granted literature
Information query
